OraSure reports 4Q revenue of $75.9 million; CEO Eglinton Manner wants `multiple shots on goal'
Revenue in the quarter was $75.9 million, exceeding the $74.6 million forecast of three analysts surveyed by Zacks Investment Research.
Stay updated with breaking news from Opus Way. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revenue in the quarter was $75.9 million, exceeding the $74.6 million forecast of three analysts surveyed by Zacks Investment Research.
The Bethlehem-based company reported results after the 4 p.m. close of regular markets Tuesday.
OraSure makes diagnostic kits, such as the InteliSwab home test for COVID-19, and the OraQuick test for HIV.
OraSure Technologies, Inc. (NASDAQ:OSUR) Q3 2023 Earnings Call Transcript November 7, 2023 OraSure Technologies, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $0.07. Operator: Good day, and thank you for standing by. Welcome to the OraSure Technologies Inc 2023 Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only […]
Operator: Good day, and thank you for standing by. Welcome to the OraSure Technologies 2023 Second Quarter Earnings Conference Call. At this time all participants are in a listen-only mode.